AMPH Stock Cash Flow Statements

Amphastar Pharmaceuticals Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Amphastar Pharmaceuticals Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30

cash flows from operating activities:
net income	31,030,000	25,285,000	37,964,000	40,429,000	37,949,000	43,177,000	36,167,000	49,222,000	26,124,000	26,032,000	33,913,000	15,874,000	17,346,000	24,253,000	19,760,000	30,960,000	8,622,000	3,959,000	-5,792,000	4,793,000	-1,429,000	3,525,000	755,000	984,000	46,920,000	-2,154,000	1,718,000	1,658,000	-2,790,000	-7,246,000		175,000	1,972,000	893,000		3,890,000	6,895,000	2,489,000	7,533,000	-3,008,000	-6,647,000	-665,000		-5,379,000
reconciliation to net cash from operating activities:
loss on disposal of assets	30,000	2,000	-101,000	2,000					5,000	2,000				1,000	10,000	24,000	308,000	6,000
gain on interest rate swaps and foreign currency transactions	-406,000	2,142,000	-4,288,000	6,085,000	56,000	-4,645,000	6,349,000	-3,453,000	2,239,000	195,000
depreciation of property, plant, and equipment	8,347,000	7,369,000	7,257,000	7,221,000	6,955,000	6,816,000	6,646,000	6,438,000	5,869,000	6,252,000	6,200,000	6,204,000	5,796,000	5,615,000	5,396,000	5,351,000	5,763,000	5,686,000	5,545,000	5,415,000	4,815,000	4,716,000	4,546,000	4,216,000	4,153,000	4,158,000	4,115,000	3,844,000	3,369,000	3,201,000		3,141,000	3,135,000	3,100,000		3,014,000	3,048,000	2,947,000	2,798,000
amortization of intangible assets	6,269,000	6,240,000
operating lease right-of-use asset amortization	1,623,000	1,598,000	1,228,000	1,033,000	997,000	980,000	964,000	953,000	922,000	903,000	902,000	895,000	881,000	828,000	795,000	782,000	826,000	863,000	960,000	993,000	852,000	848,000	823,000	798,000
amortization of discounts, premiums, and debt issuance costs	842,000	762,000	724,000	744,000	2,436,000	2,128,000	2,913,000
equity in losses of unconsolidated affiliate			0	0	0	573,000	505,000	390,000	301,000	785,000	57,000	163,000	254,000	703,000
share-based compensation expense	6,382,000	8,393,000	5,632,000	5,596,000	5,780,000	7,360,000	4,622,000	4,644,000	4,865,000	6,111,000	4,304,000	4,299,000	4,235,000	5,022,000	3,850,000	3,919,000	6,084,000	4,834,000	4,333,000	4,370,000	6,513,000	5,282,000	4,295,000	4,294,000	4,032,000	4,674,000	3,910,000	3,908,000	4,196,000	4,666,000
changes in operating assets and liabilities:
accounts receivable	12,267,000	-8,075,000	2,906,000	-8,055,000	6,679,000	-23,201,000	4,089,000	-19,642,000	1,263,000	-11,796,000	-11,555,000	3,601,000	-7,776,000	5,598,000	-755,000	-12,181,000	10,093,000	-12,078,000	-13,454,000	-2,252,000	8,033,000	-12,487,000	-20,000	5,022,000	2,761,000	-1,061,000	-8,439,000	-2,635,000	-9,856,000	4,635,000		89,000	1,900,000	920,000		-3,408,000	-34,000	10,198,000	-8,306,000	-5,156,000	1,829,000	621,000		-8,006,000
inventories	-4,821,000	-31,111,000	-24,468,000	-7,309,000	-7,025,000	-9,995,000	4,813,000	-5,770,000	-1,035,000	268,000	1,176,000	-5,500,000	-4,735,000	-2,687,000	7,026,000	-4,109,000	-515,000	-1,144,000	12,946,000	-3,409,000	3,519,000	2,241,000	43,000	-11,134,000	-20,505,000	-9,507,000	-4,100,000	-3,509,000	184,000	1,441,000		5,417,000	5,074,000	1,891,000		-2,125,000	-6,578,000	-10,774,000	1,226,000	7,985,000	5,050,000	-4,486,000		16,397,000
prepaid expenses and other assets	-4,568,000	-849,000	-237,000	-10,730,000	433,000	-192,000	-2,833,000	-635,000	521,000	219,000	-3,196,000	-2,729,000	2,651,000	1,420,000	1,109,000	853,000	491,000	1,119,000	1,706,000	-4,296,000	-953,000	1,494,000	3,000	-2,386,000	3,508,000	-4,729,000	1,804,000	-2,144,000	2,476,000	-761,000		-2,685,000	-1,450,000	344,000		-3,002,000	1,783,000	1,392,000	5,817,000	-1,527,000	-2,678,000	-2,311,000		-1,225,000
income tax refunds, deposits, and payable	-14,937,000	6,470,000	11,981,000	-4,913,000	-4,226,000	3,992,000	-28,504,000	13,218,000	5,508,000	6,459,000	14,234,000	-4,554,000	-18,161,000	3,926,000	5,517,000	614,000	1,036,000	1,182,000	1,001,000
operating lease liabilities	-1,608,000	-754,000	-884,000	-968,000	-951,000	-947,000	-922,000	-917,000	-888,000	-862,000	-851,000	-835,000	-773,000	-695,000	-669,000	-680,000	-1,095,000	-754,000	-1,119,000	-913,000	-741,000	-824,000
accounts payable and accrued liabilities	-4,858,000	17,605,000	2,112,000	24,648,000	13,725,000	23,078,000	-3,388,000	8,002,000	3,050,000	5,573,000	-13,660,000	-218,000	3,700,000	9,442,000	-1,205,000	-14,924,000	269,000	18,876,000	12,938,000	3,608,000	9,742,000	-5,679,000	-3,375,000	-11,083,000	-2,819,000	5,557,000	8,427,000	10,324,000	7,550,000	2,858,000		-6,341,000	-7,997,000	12,318,000		-867,000	-4,014,000	2,081,000	-6,594,000	-921,000	-1,976,000	6,360,000		6,305,000
net cash from operating activities	35,592,000	35,077,000	29,024,000	59,962,000	69,109,000	55,291,000	23,864,000	64,334,000	54,923,000	40,382,000	15,226,000	20,375,000	2,815,000	50,765,000	40,441,000	2,569,000	32,159,000	22,825,000	16,893,000	8,807,000	30,089,000	1,477,000	5,652,000	-12,003,000	51,723,000	-3,610,000	9,517,000	15,781,000	4,533,000	8,360,000		2,472,000	4,574,000	22,398,000		1,298,000	9,326,000	13,930,000	3,287,000	3,553,000	2,503,000	1,338,000		13,630,000
capex	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0		-6,000,000	-4,929,000	-3,528,000	-3,733,000	-3,945,000	-2,960,000	-3,780,000		-4,028,000
free cash flows	35,592,000	35,077,000	29,024,000	59,962,000	69,109,000	55,291,000	23,864,000	64,334,000	54,923,000	40,382,000	15,226,000	20,375,000	2,815,000	50,765,000	40,441,000	2,569,000	32,159,000	22,825,000	16,893,000	8,807,000	30,089,000	1,477,000	5,652,000	-12,003,000	51,723,000	-3,610,000	9,517,000	15,781,000	4,533,000	8,360,000		2,472,000	4,574,000	22,398,000		-4,702,000	4,397,000	10,402,000	-446,000	-392,000	-457,000	-2,442,000		9,602,000

cash flows from investing activities:
baqsimi® acquisition			0	0			0	-5,577,000
purchases and construction of property, plant, and equipment	-10,565,000	-10,697,000	-12,411,000	-13,793,000	-6,044,000	-8,793,000	-9,442,000	-10,193,000	-9,054,000	-9,477,000	-6,310,000	-5,623,000	-5,962,000	-6,139,000	-6,878,000	-7,219,000	-5,741,000	-7,618,000	-9,329,000	-5,631,000	-10,889,000	-8,006,000	-8,410,000	-8,678,000	-9,723,000	-14,744,000	-9,582,000	-12,635,000	-12,251,000	-12,340,000		-11,413,000	-6,301,000	-7,267,000
purchase of intangible assets																										-151,000
purchase of investments	-8,527,000	-7,092,000	-29,285,000	-25,000,000	0	-22,507,000	-91,754,000	-33,028,000	-9,200,000	-10,574,000	-5,193,000	-18,564,000	-6,687,000	-5,317,000
maturity of investments	23,034,000	28,288,000	7,484,000	5,264,000	65,777,000	47,497,000	-179,000	13,650,000	11,087,000	14,064,000	12,504,000	9,074,000	3,856,000	2,535,000
deposits and other assets	-2,317,000	-18,000	-1,466,000	-1,057,000	-636,000	-960,000	-1,674,000	3,996,000																													-2,503,000	-713,000	-339,000	592,000	-522,000	-870,000		1,089,000
net cash from investing activities	-625,000	10,481,000	-35,678,000	-34,586,000	-69,903,000	15,237,000	-103,049,000	-31,152,000	-508,582,000	-6,333,000	-229,000	-15,258,000	-8,180,000	-9,110,000	-11,954,000	-3,769,000	-4,254,000	-8,695,000	-12,176,000	-5,451,000	-10,066,000	-8,722,000	-7,352,000	-18,622,000	-9,669,000	-14,884,000	-8,797,000	-12,876,000	-11,771,000	-8,738,000		-12,970,000	-9,562,000	-6,094,000		-14,962,000	-8,006,000	-9,420,000	-4,459,000	-3,702,000	-3,719,000	-5,045,000		-3,130,000
cash flows from financing activities:
proceeds from equity plans, net of withholding tax payments	5,179,000	-4,685,000	3,385,000	3,262,000	5,815,000	-17,311,000	3,560,000	2,126,000	9,853,000	-4,565,000	2,038,000	1,400,000	5,783,000	6,437,000	5,661,000	3,870,000	7,248,000	-854,000	1,853,000	3,102,000	19,448,000	-1,238,000	1,440,000			-2,397,000	8,672,000	568,000	1,499,000	-1,793,000			9,451,000	-2,173,000
purchase of treasury stock	-39,220,000	-11,000,000	-42,002,000	-34,958,000			0	-50,001,000	-128,000	-8,015,000	-18,069,000	-14,494,000	-6,117,000	-1,229,000	-13,436,000	-6,093,000	-5,561,000	-3,783,000	-3,390,000	-4,329,000	-5,756,000	-10,950,000	-13,777,000	-4,426,000	-1,073,000	-3,015,000	-2,607,000	-7,589,000	-7,227,000	-7,624,000		-7,592,000	-8,978,000	-8,203,000		-796,000	-3,468,000	-4,722,000
debt issuance costs	-253,000	-422,000	22,000	-587,000	1,000	-252,000	-490,000	-10,439,000			-3,000	-315,000	-67,000	-22,000	-308,000
proceeds from borrowing under lines of credit	4,129,000	1,642,000	4,868,000	9,508,000	-25,000	4,082,000													166,000	367,000							0	86,000																0
principal payments on long-term debt	-37,000	-38,000	-115,000	-41,000	-8,009,000	-98,000	-50,152,000	-200,074,000	-67,464,000	-968,000	-128,000	-522,000	-593,000	-538,000	-613,000	-28,860,000	-5,265,000	-2,002,000	-2,072,000	-2,060,000	-1,941,000	-2,328,000	-1,615,000	-1,600,000	-1,562,000	-1,657,000	-1,408,000	-1,463,000	-1,423,000	-1,411,000		-5,763,000	-1,276,000	-1,342,000		-3,554,000	-1,357,000	-5,057,000	-5,018,000	-1,449,000	-1,331,000	-1,193,000		-1,117,000
net cash from financing activities	-30,202,000	-14,503,000	-33,842,000	-22,816,000	-10,716,000	-13,579,000	-47,083,000	86,613,000	428,111,000	-13,548,000	-16,162,000	-13,931,000	-994,000	4,648,000	-8,696,000	-16,492,000	-5,191,000	-6,639,000	-227,000	-3,026,000	12,456,000	-11,449,000	-10,382,000	-3,888,000	-742,000	11,229,000	16,922,000	17,804,000	1,110,000	-10,828,000		-5,513,000	10,315,000	-11,718,000		13,472,000	1,962,000	-7,033,000	-5,571,000	-3,721,000	7,084,000	4,445,000		-1,472,000
effect of exchange rate changes on cash	142,000	118,000	-11,000	-63,000	-19,000	-97,000	-238,000	-38,000	-22,000	16,000	19,000	-99,000	-111,000	-29,000	-48,000	-54,000	41,000	-162,000	242,000	192,000	64,000	-146,000	156,000	-249,000	-35,000	24,000	-39,000	-45,000	-349,000	159,000	-160,000	387,000	451,000	-174,000	124,000	130,000	46,000	-219,000	2,136,000	88,000	7,000	22,000	1,105,000	-228,000
net increase in cash, cash equivalents, and restricted cash	4,907,000	31,173,000	-40,507,000	2,497,000	-11,529,000	56,852,000	-126,506,000	119,757,000	-25,570,000	20,517,000	-1,146,000	-8,913,000	-6,470,000	46,274,000	19,743,000	-17,746,000	22,755,000	7,329,000	4,732,000	522,000			-11,926,000	-34,762,000			17,603,000	20,664,000	-6,477,000	-11,047,000
cash, cash equivalents, and restricted cash at beginning of period	0	151,844,000	0	0	0	144,531,000	0	0	0	156,333,000	0	0	0	126,588,000	0	0	0	94,507,000	0	0	0	75,550,000	0	0	0	88,202,000	0	0	0	67,459,000
cash, cash equivalents, and restricted cash at end of period	4,907,000	183,017,000	-40,507,000	2,497,000	-11,529,000	201,383,000	-126,506,000	119,757,000	-25,570,000	176,850,000	-1,146,000	-8,913,000	-6,470,000	172,862,000	19,743,000	-17,746,000	22,755,000	101,836,000	4,732,000	522,000	32,543,000	56,710,000	-11,926,000	-34,762,000	41,277,000	80,961,000	17,603,000	20,664,000	-6,477,000	56,412,000
noncash investing and financing activities:
capital expenditures included in accounts payable	-1,164,000	7,218,000	502,000	-1,610,000	787,000	5,943,000	-42,000	815,000
operating lease right-of-use assets in exchange for operating lease liabilities	0	521,000	16,418,000	638,000			631,000	7,292,000	1,448,000	1,150,000	0	389,000	0	1,777,000
supplemental disclosures of cash flow information:
interest paid, net of capitalized interest	4,090,000	7,582,000	4,422,000	8,529,000	5,228,000	8,632,000	5,475,000	9,326,000	1,527,000	1,245,000	1,063,000	793,000	588,000	579,000	241,000	870,000	490,000	508,000	521,000	559,000	560,000	559,000	561,000	597,000	379,000	898,000	648,000	650,000	546,000	532,000		542,000	402,000	390,000
income taxes paid	23,200,000	-902,000	11,104,000	12,068,000	16,583,000	349,000	46,865,000	814,000	986,000	336,000	9,276,000	11,202,000	23,781,000	183,000	2,616,000	903,000	4,547,000	30,000	604,000	2,145,000	453,000	209,000	1,528,000	3,042,000	913,000	234,000	176,000	14,000	141,000	8,000		307,000	4,129,000	440,000										2,000
impairment of long-lived assets							0	0																												0	114,000	217,000	128,000	4,000				13,000
changes in reserve for uncertain tax positions
changes in deferred taxes															-2,782,000				-3,800,000	2,000,000	0	1,638,000	-5,330,000	0															-4,339,000	6,000	564,000	-4,111,000
proceeds from the sale of property, plant and equipment											0	0																											0	18,000
proceeds from issuance of long-term debt							0	345,000,000							0				3,216,000	0	0	3,067,000					431,000	0				7,865,000				3,591,000	2,882,000	3,725,000	-1,000	0	-3,000	6,789,000		0
deferred payment for baqsimi® acquisition							0	-5,577,000
equipment acquired under finance leases											189,000				0	0	33,000	74,000	0	0			82,000	0
amortization of product rights, trademarks, and patents				6,179,000	6,193,000	6,167,000	6,179,000	6,180,000	230,000	241,000	332,000	392,000	344,000	352,000	360,000	377,000	277,000	276,000	265,000	262,000	251,000	258,000	260,000	251,000	166,000	360,000	265,000	271,000	722,000	729,000		713,000	705,000	721,000		701,000	569,000	481,000	480,000	479,000	498,000	481,000		481,000
gain on deconsolidation of subsidiary															0
anp restructuring															0
settlement of anp equity awards															0	0
repayments under lines of credit															0	-387,000							0	0																				0
gain on disposal of assets
amortization of debt issuance costs and debt modification costs
payment of deposits and other assets										-346,000	-1,230,000	-145,000	192,000	-189,000	-1,508,000	-279,000	-305,000	-520,000	-740,000	-112,000	-356,000	-206,000	48,000	-119,000	-97,000	11,000	542,000	-230,000	483,000	-597,000		238,000	-1,644,000	521,000
capital expenditure included in accounts payable										4,802,000	1,825,000	-2,108,000	-1,170,000	6,709,000	3,242,000	-788,000	796,000	6,238,000	4,659,000	-3,185,000	3,822,000	5,840,000	5,343,000	-1,352,000	120,000	6,511,000
(gain) loss on interest rate swaps and foreign currency transactions											-1,072,000
acquisition of additional ownership interest in anp																			0
(gain) loss on disposal of assets												6,000
gain on interest rate swaps													-888,000	-3,013,000
(income) loss on equity method investment
proceeds from the private placement of anp																							0	0	0	18,298,000	11,834,000
operating lease right-of-use assets															26,000	2,212,000	8,700,000	103,000	700,000				130,000	177,000
purchase of short-term investments																-5,219,000	-2,739,000	-4,501,000			1,179,000	-510,000	1,010,000				-2,000	-102,000	-3,000	-201,000		-4,384,000	303,000	-1,564,000
maturity of short-term investments																8,948,000	4,531,000	3,944,000	11,450,000								0					2,589,000	-284,000	1,345,000
sales of short-term investments
loss on impairment and disposal of assets																			79,000	131,000	16,000	14,000		19,000	45,000	805,000
sale of intangible assets																											0	0	0	4,400,000		0	1,000,000	1,000,000
income tax refunds, deposits, and payables
income tax refund, deposits, and payable																						451,000	1,222,000	-2,415,000	3,497,000	-1,713,000	2,656,000	4,417,000	-1,463,000	-1,761,000		-2,455,000	-3,152,000	394,000
net decrease in cash, cash equivalents, and restricted cash																						-18,840,000				-7,241,000
gain on impairment and disposal of assets
changes in restricted short-term investments																																0	-2,636,000	-129,000
operating lease right-of-use assets and liabilities																								-569,000
equity related tax payments, net of proceeds from equity plans
gain on disposal and impairment of long-lived assets																											1,039,000	-353,000	145,000	598,000		278,000	82,000	-2,643,000
reserve for uncertain tax positions
business acquisitions
equipment acquired under capital leases																											0	0										301,000		0	141,000	9,000
changes in short-term investments
statement of cash flow data:
net cash provided by
operating activities
investing activities
financing activities
net increase in cash and cash equivalents																															-1,326,000	-15,624,000	5,778,000	4,412,000	5,756,000	-62,000	3,328,000	-2,742,000	-4,607,000	-3,782,000	5,875,000	760,000	-5,053,000	8,800,000
net proceeds from equity plans																																				14,331,000	4,064,000	104,000	1,963,000	816,000	9,813,000	910,000
cash and cash equivalents at beginning of period																																0	0	72,354,000		0	0	66,074,000		0	0	67,828,000		0
cash and cash equivalents at end of period																																-15,624,000	5,778,000	76,766,000		-62,000	3,328,000	63,332,000		-3,782,000	5,875,000	68,588,000		8,800,000
imputed interest accretion																																	7,000	9,000		19,000	18,000	18,000	27,000	27,000	28,000	28,000
share-based compensation																																	4,298,000	4,451,000
loss on disposal of property, plant, and equipment																																						19,000	85,000			4,000		0
employee share-based compensation expense																																				3,248,000	3,836,000	3,398,000	2,997,000	2,930,000	3,533,000	2,224,000		2,406,000
non-employee share-based compensation expense																																				307,000	362,000	453,000	461,000	497,000	167,000	6,000		253,000
reserve for income tax liabilities																																								0	-531,000	547,000
income tax refund and deposits																																				2,927,000	354,000	-169,000	0					4,502,000
income taxes payable																																				-3,471,000	2,394,000	1,180,000	991,000	-696,000	-256,000	-131,000		-5,382,000
acquisition of business																																				-7,700,000	0	-4,761,000						0
purchases of property, plant, and equipment																																				-6,000,000	-4,929,000	-3,528,000	-3,733,000	-3,945,000	-2,960,000	-3,780,000		-4,028,000
capitalized labor, overhead, and interest on self-constructed assets																																				-701,000	-469,000	-418,000	-387,000	-367,000	-480,000	-395,000		-191,000
decrease (increase) in restricted cash																																				0			0	0				0
repurchase of common stock																																				-100,000	-159,000	-1,083,000	236,000	-116,000	-169,000	-572,000
gain on disposal of property, plant, and equipment
net proceeds from issuance of common stock																																												0
excess tax benefit (reduction) related to share-based compensation
cost related to public offering
deferred offering cost
principal payments on short-term debt
payments on treasury stock																																								-2,972,000	-1,226,000	-1,489,000
interest paid																																								448,000	428,000	469,000		405,000
depreciation and amortization of property, plant, and equipment																																									2,861,000	2,771,000		3,199,000
amortization of imputed interest and debt discount
purchase of trademarks and other intangible assets
payments on repurchase of common stock
net proceeds from exercise of common stock options																																												130,000
costs related to public offering																																												0

We provide you with 20 years of cash flow statements for Amphastar Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Amphastar Pharmaceuticals stock. Explore the full financial landscape of Amphastar Pharmaceuticals stock with our expertly curated income statements.

The information provided in this report about Amphastar Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.